Por: Fox Business Business October 10, 2023
FOX Business' Lydia Hu has the latest on the backbone of oncology treatment on 'The Big Money Show.' Bristol Myers Squibb said Sunday it will acquire drugmaker Mirati Therapeutics in a deal worth up to $5.8 billion, adding to its oncology business portfolio. The company said it will pay $58 per share in cash. As part of the deal, Mirati stockholders will also receive one non-tradeable contingency value for each Mirati share held,... + full article
MarketWatch USA Business October 09, 2023
(LMT) rose 7.9% and shares of other such as (RTX), up 4.2%, and (NOC), up 8.5%, also traded higher following Israel’s war with Hamas. Separately, ‘s board on Friday approved the expansion of Lockheed’s stock repurchase program by $6 billion, and the company raised its... + más
Alnylam signs $2.8 billion deal with Roche to advance Cambridge biotech’s injection for high blood pressure | The Boston Globe
Alnylam’s experimental Alzheimer’s drug shows benefits in patients for six months | The Boston Globe
Business Insider USA Business July 26, 2023
Jump to 0 An icon in the shape of a person's head and shoulders. It often indicates a user profile. An icon in the shape of a person's head and shoulders. It often indicates a user profile. All Featured About Follow Subscriptions US Markets Loading... H M S In the news... + más
Saints' Derek Carr on injury: If I'm out there, then 'I'm good' | ABC News
Healthy Mayfield 'rolling with the punches' as QB2 | ESPN
ABC News USA Sports July 26, 2023
Joe Lewis, the British billionaire and owner of the Tottenham Hotspur soccer team, was criminally charged on Tuesday in New York for orchestrating a brazen insider trading scheme.Prosecutors said Lewis exploited his access to corporate boardrooms by passing tips about companies... + más
English Premier League's Tottenham Hotspur announces 15-year partnership with Formula 1 | Fox Business
Kane's milestone goal gives Tottenham win, helps Arsenal too | WPLG Local 10
Forbes USA Life March 26, 2023
Le Bristol Paris is making waves in the metaverse.Le Bristol A couple of years shy of its centenary, Paris’ Le Bristol hotel is making its web3 debut with the launch of Le Bristol Unlocked, 11 exclusive NFTs (the number corresponds to the hotel’s 11 signature suites) which... + más
NFL Playoff Scenarios | ABC News
Council Post: Web 3.0 And The Metaverse In 2023 | Forbes
Fox Business USA Business March 09, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal discusses the promising Alzheimer drug that is expected to receive full approval from the FDA this summer on ‘Varney & Co.’ A new Amgen Inc. lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in... + más
Goldman Sachs just dropped the names of its biggest partner class since David Solomon took over as CEO. See the full list here. | Business Insider
Sky Stream arrives next month to give you Sky TV without a satellite dish | The Verge
Forbes USA Business February 08, 2023
Pamela Fisher, chief diversity officer of Bristol Myers Squibb (BMS)Bristol Myers Squibb Pamela Fisher may be the chief diversity officer of Bristol Myers Squibb (BMS), but she’s also an advocate for underrepresented communities. In this role, Fisher uses the vehicles of... + más
Togus VA officials do not know when family accommodations on campus will reopen following October closure | Portland Press Herald
Jeff Fisher and the 1999 AFC championship: How the Jaguars-Titans rivalry began | ESPN
RTTNews USA Health October 12, 2022
Oncology company Mirati Therapeutics, Inc. () and biopharmaceutical company Aadi Bioscience, Inc. () announced Wednesday a clinical collaboration to evaluate the combination of adagrasib, a KRASG12C selective inhibitor, and nab-sirolimus, a small molecule mTOR inhibitor... + más
A New Approach to Spotting Tumors: Look for Their Microbes | The New York Times
A Devious Cellular Trick Cancers Can Use to Escape Your Immune System | The New York Times
About iurex | Privacy Policy | Disclaimer |